Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: J Heart Lung Transplant. 2021 Jul 24;41(2):161–170. doi: 10.1016/j.healun.2021.07.011

Figure 1. Intermacs Subgroups According to Duration of cfLVAD support.

Figure 1.

Patients were sub-grouped according to survival on cfLVAD support. Patients on mid-term support (MT) were alive on support 1–3 years and those on long-term support (LT) were alive on support for ≥3 years. Y= years. cfLVAD= continuous flow left ventricular assist device